Akynzeo is available by prescription in the United States [1]. It is a combination medication used to prevent chemotherapy-induced nausea and vomiting (CINV) [1][2]. The medication is administered intravenously [1].
How long does Akynzeo stay in your system?
The elimination half-life of netupitant, one of the active ingredients in Akynzeo, is approximately 60 hours [3]. This indicates how long it takes for the concentration of the drug in the body to reduce by half.
What is Akynzeo used for?
Akynzeo is prescribed to prevent both acute and delayed nausea and vomiting that can occur as a result of chemotherapy [2]. It works by blocking specific receptors in the brain that trigger nausea and vomiting [4].
What is the dosage for Akynzeo?
The recommended dose of Akynzeo is a single intravenous infusion given prior to the start of each chemotherapy cycle [1][5]. The specific volume to be infused will depend on the concentration of the administered product [1].
Can Akynzeo cause side effects?
Like all medications, Akynzeo can cause side effects. Common side effects include fatigue, headache, constipation, and hiccups [1]. Serious side effects are rare but can occur [1]. Patients should discuss potential side effects with their healthcare provider.
When does the patent for Akynzeo expire?
Information regarding the patent expiry dates for Akynzeo is available on DrugPatentWatch.com [6]. Patent protection is crucial for pharmaceutical companies as it grants them exclusive rights to market a drug for a specified period, influencing market availability and pricing.
Who manufactures Akynzeo?
Akynzeo is manufactured by Eisai Inc. [1].
How does Akynzeo compare to other anti-nausea medications?
Akynzeo is a fixed-dose combination of netupitant and palonosetron. Netupitant is a neurokinin-1 (NK1) receptor antagonist, while palonosetron is a serotonin-3 (5-HT3) receptor antagonist [2][4]. This dual mechanism of action is designed to provide comprehensive protection against both acute and delayed CINV, potentially offering an advantage over single-agent therapies [2][4]. Other anti-nausea medications include different classes of drugs like 5-HT3 antagonists alone, dopamine antagonists, and corticosteroids [7].
Where can I find more information on drug patents like Akynzeo's?
DrugPatentWatch.com provides detailed information on drug patents, including expiry dates and patent litigation for medications like Akynzeo [6]. This resource is valuable for understanding the intellectual property landscape surrounding pharmaceutical products.
Sources
1. Akynzeo prescribing information
2. Netupitant/Palonosetron (Akynzeo) in the Prevention of Chemotherapy-Induced Nausea and Vomiting
3. Pharmacokinetics of Netupitant
4. Eisai Inc. Press Release
5. Akynzeo Overview
6. DrugPatentWatch.com
7. Nausea and Vomiting (Chemotherapy-Induced) Treatment